Okay, let's tackle this question. The question is about karyotyping a fetus and which method isn't used. The options aren't provided, but I need to figure out the possible scenarios.

First, I need to recall what karyotyping involves. Karyotyping is a test that examines the chromosomes of a cell to detect abnormalities. For a fetus, this is typically done through procedures that obtain fetal cells. Common methods include amniocentesis, chorionic villus sampling (CVS), and sometimes percutaneous umbilical blood sampling (PUBS). These methods allow for the collection of fetal cells to analyze the chromosomes.

Now, the question asks which method is NOT used. Let's think about possible options. If the options include something like maternal blood alone, that might be the answer. Maternal blood can be used for non-invasive prenatal testing (NIPT), which screens for certain chromosomal abnormalities, but it's not traditional karyotyping. Karyotyping requires a cell culture to analyze all chromosomes in detail, which NIPT doesn't do.

Another possibility is using ultrasound. Ultrasound can detect structural abnormalities but doesn't provide a karyotype. So if an option says "ultrasound," that's not a method for karyotyping. Similarly, methods like amniocentesis or CVS are standard, so if those are options, they're correct. If the options include something like "fetal skin biopsy," that's not a standard method for karyotyping, though it's possible in some contexts. But more commonly, the non-invasive methods versus invasive ones.

Wait, the question is about which is not used. So the incorrect option would be a method that doesn't provide fetal cells for karyotyping. Let's consider possible distractors. If the options are amniocentesis, CVS, PUBS, and maternal blood test, then the answer is maternal blood. Because while maternal blood is used for screening (like NIPT), it's not for a full karyotype. Similarly, if an option is "fetal ultrasound," that's not a karyotyping method.

So, the core concept here is understanding the methods available for fetal karyotyping. The correct answer would be the one that's not a source of fetal cells for karyotype analysis. The wrong options would be invasive procedures that do provide fetal cells. The clinical pearl is that karyotyping requires a source of fetal cells, and non-invasive methods like maternal blood can't provide a full karyotype. High-yield fact: NIPT is for screening, not diagnostic karyotyping.

**Core Concept**
Karyotyping a fetus involves analyzing its chromosomes to detect abnormalities. This requires obtaining fetal cells via invasive procedures like amniocentesis, chorionic villus sampling (CVS), or percutaneous umbilical cord blood sampling (PUBS). Non-invasive methods like maternal blood alone cannot provide a full karyotype.

**Why the Correct Answer is Right**
**Maternal serum screening** (e.g., first-trimester combined screening or second-trimester quad screen) assesses risk for chromosomal abnormalities via biochemical markers but does **not** provide a karyotype. It lacks fetal cell sampling, which is necessary for detailed chromosomal analysis.

**Why Each Wrong Option is Incorrect**
**Option A:** Amniocentesis

✓ Correct Answer: B. Monocyte